December 4, 2024 - 04:41

Salesforce (CRM) and Okta (OKTA) are scheduled to release their earnings reports after the market closes, shedding light on the current state of the software industry. Marvell Technology (MRVL) will also unveil its financial results, adding to the day's significant announcements. As these companies prepare to disclose their performance, the stock markets are experiencing a period of stability, hovering around the flat line following record highs for both the S&P 500 and Nasdaq Composite.
With the impending second term of President-elect Donald Trump, investors are closely analyzing the potential effects of his tariff policies on various sectors. The market sentiment is mixed, with traders keeping a watchful eye on how these earnings reports may influence stock prices.
In addition to the earnings announcements, several key guests will be featured throughout the day, including investment strategists and industry leaders from various companies. Their insights may provide valuable perspectives on market trends and economic forecasts as investors navigate this pivotal time.
March 15, 2026 - 03:23
Audit finds strong oversight at Fort Worth Housing Finance Corp, flags minor control gapsA recent operational audit of the Fort Worth Housing Finance Corporation has concluded that the agency maintains strong overall oversight, though it identified a handful of minor internal control...
March 14, 2026 - 07:39
Nvidia GTC, Macy's earnings, FOMC meeting: What to WatchThe upcoming week presents a critical lineup of events for the financial markets, with major corporate developments and a key Federal Reserve meeting on the calendar. All eyes will be on the...
March 13, 2026 - 20:57
Richard Donoff Encourages Americans to Prioritize Long-Term Financial PreparednessIn a recent address, financial expert Richard Donoff emphasized the critical need for American families to shift their focus toward long-term financial preparedness. He advocates for a proactive...
March 13, 2026 - 04:55
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateCapricor Therapeutics has announced its financial results for the fourth quarter and full year 2025, alongside significant progress in its lead clinical program. The company`s Biologics License...